TrialVaccine2026

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.

Fei Heng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.